Table II.

Characteristics of patients with hepatic dysfunction (n=17).

Patient characteristics	No. of patients (%)
Discrete variables
Gender
Male	13 (76.47)
Female	4 (23.53)
AJCC stage
IB	0 (0)
II	4 (23.53)
III	10 (58.82)
IV	3 (17.65)
Radiotherapy
Yes	12 (70.59)
No	5 (29.41)
Chemotherapy cycles
<6	8 (47.06)
≥6	9 (52.94)
Virus reactivation
Yes	8 (47.06)
No	9 (52.94)
Continuous variables
Age (years), median (range)	51 (35–72)

AJCC, American Joint Committee on Cancer.